Zymeworks Inc. Files 2024 10-K

Ticker: ZYME · Form: 10-K · Filed: Mar 5, 2025 · CIK: 1937653

Sentiment: neutral

Topics: 10-K, annual-report, pharmaceuticals

TL;DR

Zymeworks filed its 2024 10-K. Financials for FY24 are in. Check it out.

AI Summary

Zymeworks Inc. filed its 2024 10-K on March 5, 2025, reporting its fiscal year ending December 31, 2024. The company, previously known as Zymeworks Delaware Inc., changed its name on July 12, 2022. The filing details its financial performance and business operations for the fiscal year 2024, with comparative data from 2023 and 2022.

Why It Matters

This 10-K filing provides a comprehensive overview of Zymeworks Inc.'s financial health and strategic direction for the fiscal year 2024, crucial for investors and stakeholders to assess the company's performance and future prospects.

Risk Assessment

Risk Level: medium — As a pharmaceutical company, Zymeworks faces inherent risks related to drug development, regulatory approvals, and market competition, which are detailed in its 10-K filing.

Key Numbers

Key Players & Entities

FAQ

What is Zymeworks Inc.'s primary industry classification?

Zymeworks Inc. is classified under Pharmaceutical Preparations [2834].

When did Zymeworks Inc. change its name?

The company changed its name from Zymeworks Delaware Inc. on July 12, 2022.

What is the filing date of this 10-K report?

This 10-K report was filed on March 5, 2025.

What is the fiscal year end date for Zymeworks Inc. as reported in this filing?

The fiscal year end date is December 31, 2024.

What is Zymeworks Inc.'s business phone number?

The business phone number listed is 302-274-8744.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on March 5, 2025 regarding Zymeworks Inc. (ZYME).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on Read The Filing